The growing demand for novel drugs that can acts as potential treatments for previously untreatable intracellular targets has resulted in an adjacent and urgent need for efficient delivery systems that facilitate intracellular transport of therapeutics across the cytosol

The financial opportunity within non-viral drug delivery systems market has been analyzed across the following segments:

• Type of Molecule
• Small Molecule
• Biologic

• Type of Biologic
• Antibodies
• DNA
• RNA
• Proteins / Peptides

• Type of Intracellular Drug Delivery Technologies
• Cell Penetrating Peptides
• Extracellular Vesicles
• Oligonucleotides
• Nanoparticles
• Polymers

• Target Therapeutic Area
• Infectious Diseases
• Oncological Disorders
• Genetic Disorders
• Neurological Disorders
• Hepatic Disorders
• Cardiovascular Disorders
• Other Disorders

• Type Of Payment Model
• Upfront Payments
• Milestone Payments

• Key Geographical Regions 
• North America
• Europe
• Asia
• Latin America
• Middle East and North Africa (MENA)
• Rest of the world 

The Non-Viral Drug Delivery Systems Market: Focus on Intracellular Technologies and Biologics (2nd Edition), 2022-2035, report features the following companies, which we identified to be key players in this domain:

• Alnylam Pharmaceuticals
• AstraZeneca
• Biond Biologics
• Code Biotherapeutics
• Eli Lilly
• Merck
• Novartis
• Roche

Table of Contents

1. Preface
2. Executive Summary

3. Introduction
4. Market Landscape
5. Key Insights
6. Company Competitiveness Analysis
7. Company Profiles
8. Patent Analysis
9. Partnerships and Collaborations
10. Opportunity Assessment Framework
11. Market Forecast
12. Conclusion
13. Executive insights
14. Appendix I: Tabulated data
15. Appendix II: List of Companies and Organizations

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html

You may also be interested in the following titles:

You may also like to learn what our experts are sharing in Roots educational series:

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

[email protected]